Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Elisabeth Arrojo"'
Autor:
Pedro J. Prada, María Ferri, Juan Cardenal, Ana García Blanco, Elisabeth Arrojo, Javier Anchuelo, Ivan Diaz de Cerio, Pedro Lastra, Alejandro Fernández, Andrés Vázquez, Samuel Ruiz Arrebola
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 959 (2022)
Purpose: To evaluate the reduction in the absorbed dose delivered to the neurovascular bundle (NB) in patients with localized prostate cancer treated with only HDR brachytherapy and NB protection with hyaluronic acid (HA) on the side of the prostate
Externí odkaz:
https://doaj.org/article/2ba01001cdb9473790b7937e056f4a39
Autor:
Elisabeth Arrojo, Giammaria Fiorentini, Pirus Ghadjar, Carrie Minnaar, A. Marcell Szasz, Andras Szasz
Publikováno v:
Clinical and experimental medicine. 22(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6518d5dc863de8471442367664c87808
https://pubmed.ncbi.nlm.nih.gov/36239870
https://pubmed.ncbi.nlm.nih.gov/36239870
Autor:
P. Lastra, A. García Blanco, Andrés Vázquez, Javier Anchuelo, Juan Cardenal, María Ferri, S. Ruiz Arrebola, Elisabeth Arrojo, Nicolas Sierrasesumaga, Pedro J. Prada, Arantzazu Rodríguez Fernández, I. Diaz de Cerio
Background: To evaluate the reduction, the absorbed dose delivered to the neurovascular bundle (NB) in patients with localized prostate cancer treated with only HDR brachytherapy and neurovascular bundle protection with Hyaluronic acid (HA) on the si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67524f82af96dc6daf26bb7ad2efc375
https://doi.org/10.21203/rs.3.rs-58759/v1
https://doi.org/10.21203/rs.3.rs-58759/v1
Autor:
Gema Fernández, Juan Cardenal, María Ferri, Javier Anchuelo, Jose Fernández, A. Blanco, Andrés Vázquez, Maite Pacheco, Elisabeth Arrojo, P.J. Prada
Publikováno v:
Radiotherapy and Oncology. 119:411-416
Background To evaluate acute and late genitourinary, the gastrointestinal toxicity and the long-term biochemical control after HDR monotherapy in one fraction (19Gy). Patients and methods Between April 2008 and October 2010, 60 consecutive patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a03d1de7196c53230077b4f0239e824
https://doi.org/10.1016/j.radonc.2016.04.006
https://doi.org/10.1016/j.radonc.2016.04.006
Autor:
Isabel Jimenez, Lucia Mendez, Pedro J. Prada, José Tejada Fernández, Elisabeth Arrojo, Herminio González
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 7, Iss 1, p 31 (2012)
Radiation Oncology, Vol 7, Iss 1, p 31 (2012)
Background Biochemical control from series in which radical prostatectomy is performed for patients with unfavorable prostate cancer and/or low dose external beam radiation therapy are given remains suboptimal. The treatment regimen of HDR brachyther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d29abaf694121cabfa3ff23882b15fda